The development of new therapeutics targeting protein kinases is crucial in the fight against diseases like cancer.

A new, fast and easy test could revolutionize blood transfusions-giving blood centers and hospitals a reliable way to monitor the quality of red blood cells after they sit for weeks in storage. The ...

Objectives Understanding the molecular changes in the preclinical synovium is crucial for identifying factors that drive ...

The most successful players — both old and new — are those focusing on operational risk control rather than assay novelty.

Mira is bringing its version of Oxford Cancer Biomarkers' PGx test to the US in the newly launched ToxNav Advantage assay.